ZFIN ID: ZDB-FISH-200714-15
Fish name: WT + MO1-got2a
Genotype: WT
Targeting Reagent: MO1-got2a
HUMAN DISEASE MODELED by WT + MO1-got2a
Human Disease Conditions Citations
early infantile epileptic encephalopathy standard conditions van Karnebeek et al., 2019
developmental and epileptic encephalopathy 82 standard conditions van Karnebeek et al., 2019
GENE EXPRESSION
Gene expression in WT + MO1-got2a
RNA expression No data available
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in WT + MO1-got2a
Phenotype Conditions Figures
blood circulation decreased rate, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019
brain cell communication by electrical coupling disrupted, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019
brain cell communication by electrical coupling disrupted, ameliorated chemical treatment by environment: pyridoxine Fig. 5 from van Karnebeek et al., 2019
head decreased size, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019
head decreased size, abnormal chemical treatment by environment: L-proline Fig. 5 from van Karnebeek et al., 2019
head decreased size, ameliorated chemical treatment by environment: pyridoxine, chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
head decreased size, ameliorated chemical treatment by environment: sodium pyruvate Fig. 5 from van Karnebeek et al., 2019
head decreased size, ameliorated chemical treatment by environment: pyridoxine Fig. 5 from van Karnebeek et al., 2019
head decreased size, ameliorated chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
pericardium edematous, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019
pericardium edematous, abnormal chemical treatment by environment: L-proline Fig. 5 from van Karnebeek et al., 2019
pericardium edematous, ameliorated chemical treatment by environment: pyridoxine, chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
pericardium edematous, ameliorated chemical treatment by environment: pyridoxine Fig. 5 from van Karnebeek et al., 2019
pericardium edematous, ameliorated chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
pericardium edematous, ameliorated chemical treatment by environment: sodium pyruvate Fig. 5 from van Karnebeek et al., 2019
whole organism curved, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019
whole organism curved, abnormal chemical treatment by environment: L-proline Fig. 5 from van Karnebeek et al., 2019
whole organism curved, ameliorated chemical treatment by environment: pyridoxine Fig. 5 from van Karnebeek et al., 2019
whole organism curved, ameliorated chemical treatment by environment: pyridoxine, chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
whole organism curved, ameliorated chemical treatment by environment: sodium pyruvate Fig. 5 from van Karnebeek et al., 2019
whole organism curved, ameliorated chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
whole organism viability, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019
whole organism viability, abnormal chemical treatment by environment: L-proline Fig. 5 from van Karnebeek et al., 2019
whole organism viability, abnormal chemical treatment by environment: sodium pyruvate Fig. 5 from van Karnebeek et al., 2019
whole organism viability, ameliorated chemical treatment by environment: pyridoxine Fig. 5 from van Karnebeek et al., 2019
whole organism viability, ameliorated chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
yolk increased size, abnormal chemical treatment by environment: L-proline Fig. 5 from van Karnebeek et al., 2019
yolk increased size, abnormal chemical treatment by environment: sodium pyruvate Fig. 5 from van Karnebeek et al., 2019
yolk increased size, abnormal chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
yolk increased size, abnormal chemical treatment by environment: pyridoxine Fig. 5 from van Karnebeek et al., 2019
yolk increased size, abnormal chemical treatment by environment: pyridoxine, chemical treatment by environment: serine Fig. 5 from van Karnebeek et al., 2019
yolk increased size, abnormal standard conditions Fig. 5 from van Karnebeek et al., 2019

CITATIONS  (1)